Literature DB >> 18299389

Regulation of transcription factor NFAT by ADP-ribosylation.

Opeyemi A Olabisi1, Noemi Soto-Nieves, Edward Nieves, Teddy T C Yang, Xiaoyong Yang, Raymond Y L Yu, Hee Yun Suk, Fernando Macian, Chi-Wing Chow.   

Abstract

ADP-ribosylation is a reversible posttranslational modification mediated by poly-ADP-ribose polymerase (PARP). The results of recent studies demonstrate that ADP-ribosylation contributes to transcription regulation. Here, we report that transcription factor NFAT binds to and is ADP-ribosylated by PARP-1 in an activation-dependent manner. Mechanistically, ADP-ribosylation increases NFAT DNA binding. Functionally, NFAT-mediated interleukin-2 (IL-2) expression was reduced in T cells upon genetic ablation or pharmacological inhibition of PARP-1. Parp-1(-/-) T cells also exhibit reduced expression of other NFAT-dependent cytokines, such as IL-4. Together, these results demonstrate that ADP-ribosylation mediated by PARP-1 provides a molecular switch to positively regulate NFAT-dependent cytokine gene transcription. These results also imply that, similar to the effect of calcineurin inhibition, PARP-1 inhibition may be beneficial in modulating immune functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299389      PMCID: PMC2293084          DOI: 10.1128/MCB.01746-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines.

Authors:  K Schuh; B Kneitz; J Heyer; F Siebelt; C Fischer; E Jankevics; E Rüde; E Schmitt; A Schimpl; E Serfling
Journal:  Immunol Lett       Date:  1997-06-01       Impact factor: 3.685

2.  Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene.

Authors:  J W Rooney; T Hoey; L H Glimcher
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

Review 3.  Cyclosporine neurotoxicity.

Authors:  M Hauben
Journal:  Pharmacotherapy       Date:  1996 Jul-Aug       Impact factor: 4.705

4.  The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun.

Authors:  J Jain; P G McCaffrey; Z Miner; T K Kerppola; J N Lambert; G L Verdine; T Curran; A Rao
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

5.  Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site.

Authors:  P M Campbell; J Pimm; V Ramassar; P F Halloran
Journal:  Transplantation       Date:  1996-03-27       Impact factor: 4.939

6.  An enhanced immune response in mice lacking the transcription factor NFAT1.

Authors:  S Xanthoudakis; J P Viola; K T Shaw; C Luo; J D Wallace; P T Bozza; D C Luk; T Curran; A Rao
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

7.  Nuclear factor of activated T cells contains Fos and Jun.

Authors:  J Jain; P G McCaffrey; V E Valge-Archer; A Rao
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

8.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.

Authors:  N A Clipstone; G R Crabtree
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

9.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice.

Authors:  M R Hodge; A M Ranger; F Charles de la Brousse; T Hoey; M J Grusby; L H Glimcher
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

10.  A common factor regulates both Th1- and Th2-specific cytokine gene expression.

Authors:  J W Rooney; M R Hodge; P G McCaffrey; A Rao; L H Glimcher
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

View more
  48 in total

Review 1.  Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer.

Authors:  Alexander König; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

Review 2.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

3.  Enzymatic synthesis and structural characterization of 13C, 15N-poly(ADP-ribose).

Authors:  Heather L Schultheisz; Blair R Szymczyna; James R Williamson
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

Review 4.  Metabolic checkpoints in activated T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

5.  Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

Authors:  Kaishun Hu; Wenjing Wu; Yu Li; Lehang Lin; Dong Chen; Haiyan Yan; Xing Xiao; Hengxing Chen; Zhen Chen; Yin Zhang; Shuangbing Xu; Yabin Guo; H Phillip Koeffler; Erwei Song; Dong Yin
Journal:  EMBO Rep       Date:  2019-04-02       Impact factor: 8.807

Review 6.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

7.  PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Authors:  Qian Li; Zhuo-Ming Li; Shu-Ya Sun; Lu-Ping Wang; Pan-Xia Wang; Zhen Guo; Han-Wei Yang; Jian-Tao Ye; Jing Lu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

Review 8.  Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation.

Authors:  W Lee Kraus
Journal:  Curr Opin Cell Biol       Date:  2008-04-29       Impact factor: 8.382

Review 9.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 10.  Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Authors:  Maria Manuela Rosado; Elisabetta Bennici; Flavia Novelli; Claudio Pioli
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.